ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,067.00
-1.24%
S&P ASX All Technology
3,766.30
-0.74%
Brent Oil
72.72
0.00%
US Dollar vs AUD
1.59949
0.00%
Bitcoin
96,621.23
-0.60%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. ETFs
  4. USA
  5. AMEX

  6. Emles at Home ETF (LIV) Share Price

Emles at Home ETF

Emles at Home ETF (LIV)

Livermore Investments Group Limited
Autoliv Inc
15.725
0.00
(0.00%)
Closed 22 December 8:00AM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
15.725
Bid
-
Offer
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
15.725
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

LIV Latest News

More News

Emles Advisors Announces Closure of Six Funds

Emles Advisors Announces Closure of Six Funds PR Newswire NEW YORK, Sept. 16, 2022 NEW YORK, Sept. 16, 2022 /PRNewswire/ -- Due to the inability to attract sufficient investment assets and based...

17 September 2022
PR Newswire (US)

Samaritan to Initiate Phase III Clinical Trial in Europe to Accelerate Development Timeline of Its HIV Oral Entry Inhibitor SP0

Samaritan Pharmaceuticals Inc. (AMEX:LIV): ? -- Trial Designed to Tackle HIV Drug Resistance (One or More of a Patient's Current HIV Drug Regime Stops Working Leading to a Lack of Treatment...

16 June 2006
Business Wire

Samaritan Reports Positive Preliminary Results with ''Oral'' HIV Entry Inhibitor in Phase II 10-Day HIV Monotherapy Trial

Samaritan Pharmaceuticals Inc. (AMEX:LIV): ? -- Data Shows 0.4 log10 Difference Between the High-Dose and the Placebo Control Group ? -- Dose dependent relationship in the number of subjects...

30 May 2006
Business Wire

Samaritan Files Provisional Patent to Support Promising New Type of Anti-cholesterol Drug SP-1000 and Cover Additional Claims;

Samaritan Pharmaceuticals Inc. (AMEX:LIV): ? -- Clears Clogged Arteries ? -- Raises HDL ? -- Reduces CK Enzyme Marker: Suggesting It Improves, Hypercholesterolemia-Related Heart Suffering...

23 May 2006
Business Wire

Samaritan Starts Enrolling for Its PII Stage 2 (28 Day Monotherapy) Study of ''Oral'' Entry Inhibitor SP-01A

Samaritan Pharmaceuticals (AMEX:LIV): ? -- Completed Phase II Stage 1 (10 Day Monotherapy) ? -- Expect to Report Stage I Preliminary Results at Shareholders Meeting May 31st ? -- Expect...

02 May 2006
Business Wire

SIS Foundation Driven to Drive Bio Future Bus So Kids Can Speed up Science Innovation; Only 17% of US Students Graduate with Sc

The Samaritan Foundation and Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today on National DNA day, it is driven to raise money to bring its...

25 April 2006
Business Wire

Bio 2006 Analysts Predict Small-Cap Biotechs to Outperform Large-Caps This Year

Samaritan Pharmaceuticals Inc. (AMEX:LIV) ? -- David W. Munno, Merrill Lynch VP of biotechnology, stated, "Large-cap biotech firms need some blockbuster products for meaningful growth which is...

14 April 2006
Business Wire

LIV to Host Annual Shareholders Meeting

Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, its shareholders are invited to the Annual Shareholders Meeting on Wednesday, May 31, 2006 10 a.m. at...

06 April 2006
Business Wire

Samaritan's Marketing Authorization Application For Amphocil Approved in Greece

Samaritan Pharmaceuticals, Inc. (AMEX:LIV) is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received notification by the National Pharmaceuticals Organization...

04 April 2006
Business Wire

Samaritan to Present Its Drugs and Diagnostics for Partnering at BIO 2006 Annual International Conference

Samaritan Pharmaceuticals Inc. (AMEX:LIV): ? -- PII/III HIV Oral Entry Inhibitor Drug ? -- Cardiovascular Drug SP-1000 ? -- Alzheimer's Drug SP-233 ? -- Alzheimer's Blood Diagnostic ?...

31 March 2006
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ODEOOdessa Minerals Ltd
AUD 0.002
(100.00%)
500k
LM1Leeuwin Metals Ltd
AUD 0.10
(66.67%)
468.95k
RADORadiopharm Theranostics Ltd
AUD 0.008
(60.00%)
200k
PKOPeako Limited
AUD 0.003
(50.00%)
166.67k
ENVOEnova Mining Ltd
AUD 0.003
(50.00%)
250k
JAYJayride Group Limited
AUD 0.003
(-40.00%)
5.13M
CZNCorazon Mining Ltd
AUD 0.002
(-33.33%)
7.71M
1AIOAlgorae Pharmaceuticals Ltd
AUD 0.002
(-33.33%)
1.55M
GTRGTI Energy Ltd
AUD 0.003
(-25.00%)
5.68M
TTITraffic Technologies Ltd
AUD 0.003
(-25.00%)
4.6M
VAUVault Minerals Ltd
AUD 0.325
(-1.52%)
52.89M
EVNEvolution Mining Ltd
AUD 4.80
(0.00%)
38.65M
RSGResolute Mining Limited
AUD 0.4025
(0.63%)
37.61M
SYASayona Mining Limited
AUD 0.0255
(4.08%)
36.86M
MSBMesoblast Limited
AUD 2.40
(-21.31%)
34.45M

Discussion

View Full Feed
BDEZ BDEZ 3 minutes ago
Google announces 10% job cuts in managerial roles, including directors & VP's...
BDEZ BDEZ 4 minutes ago
IGEX
IGEX
BDEZ BDEZ 4 minutes ago
LODE
BDEZ BDEZ 4 minutes ago
ICTY
ICTY
BDEZ BDEZ 4 minutes ago
WCVC
BDEZ BDEZ 4 minutes ago
DPLS
DPLS
BDEZ BDEZ 5 minutes ago
good evening 02, mick & bbcers....
BDEZ BDEZ 5 minutes ago
thanks for the posts 02....
NoMoDo NoMoDo 6 minutes ago
That works for me. I will take .02 in 8 days.
HMBL
BDEZ BDEZ 6 minutes ago
Google announces 10% job cuts in managerial roles, including directors and VP"s.....
Squirrely_McShitty Squirrely_McShitty 7 minutes ago
Let me add this...

I never said CNNA was dead, I said the available data points make that outcome appear more likely - in some form or another - than any other.

All the publicly-available data points say to me it's abandoned, it's dead, or it's kept alive by artificial
CNNA
facts_matter14 facts_matter14 7 minutes ago
How many times will we get a BSR report on Christmas Eve Day and on Christmas Day combined???

Over/Under is 5

Place your bets……………




.
SRMX
carlson carlson 8 minutes ago
LIKE!
NBRI
williamssc williamssc 8 minutes ago
Give me a break, if the trial failed as you say the application wouldn't even be excepted so no long wait. You can't have it both ways. I also see you post words from other posters even if they may be wrong. The trial was successful. Watch and learn.
AVXL
Motor-goater Motor-goater 8 minutes ago
Wasn’t asking you… I was asking HI-HO and I’m always glad to see you here!

Sorry for any confusion.
CNNA
krab krab 9 minutes ago
Excellent piece by David Fiderer. Everyone on this board needs to read, well written, short & precise that covers 24 items !!
FNMA
janice shell janice shell 9 minutes ago
Interesting. I'm pretty sure I've never seen it.

But I HAVE read War and Peace!! Once when I had the flu...
arizona1 arizona1 9 minutes ago
https://bsky.app/profile/marcelias.bsky.social/post/3ldtjxk5gf22z
georgejjl georgejjl 11 minutes ago
Look at slide#/page# 7 from the presentation at the following link and look at the rows that are highlighted in red rectangles. Those baseline characteristics are:

APOE e4 Homozygotes,
MMSE mean value of 23.6,
MCI due to AD (CDR-global = 0.5),
The vast majorit
AVXL
Itsarip Itsarip 12 minutes ago
.965 EOY
ELTP
sam1933 sam1933 12 minutes ago
Coinbase releases 2025 crypto market outlook, focusing on five areas

1. Stablecoins

2. RWA tokenization

3. Crypto ETFs

4. The DeFi

5. Regulation
HBARUSD
Acme Investments Acme Investments 14 minutes ago
Beautiful cover girl?? Lol!! That's the only time I've read a man say that!! Reminds me of that Seinfeld episode when he had to wear a ladies fur coat in front of the Super!! Love me, touch me!! Lol!!
RDAR
realest8 realest8 14 minutes ago
I have to agree, I'm thinking they extended the portal purchase for a reason!
VXIT

Your Recent History

AMEX
LIV
Emles at Home ETF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads